Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINIPREM: Fludrocortisone in Very Premature Infants
NCT03001089Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2017
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fludrocortisone in hypoaldosteronism, sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2017; status: completed.
02
Drugs
fludrocortisone
03
Conditions
hypoaldosteronism
Beyond the preview
Go deeper on NCT03001089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03001089.